Submissions from 2022
Nephron overload as a therapeutic target to maximize kidney lifespan., Valerie A Luyckx, Andrew D Rule, Katherine Tuttle, Pierre Delanaye, Helen Liapis, Afschin Gandjour, Paola Romagnani, and Hans-Joachim Anders
Accuracy and agreement of a large panel of endosonographers for endomicroscopy-guided virtual biopsy of pancreatic cystic lesions., Jorge D Machicado, Bertrand Napoleon, Anne Marie Lennon, Samer El-Dika, Stephen P Pereira, Damien Tan, Rahul Pannala, Mohit Girotra, Pradermchai Kongkam, Helga Bertani, Yunlu Feng, Hao Sijie, Ning Zhong, Vincent Valantin, Sarah Leblanc, Alice Hinton, and Somashekar G Krishna
Successful electroconvulsive therapy after failed pharmacotherapies in an older female on hemodialysis with bipolar mania., Ian R McGrane, Robert C Munjal, Shelby L Skauge, and Jason R Molinaro
A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis., Michelle T McNulty, Damian Fermin, Felix Eichinger, Dongkeun Jang, Matthias Kretzler, Noël P Burtt, Martin R Pollak, Jason Flannick, Astrid Weins, David J Friedman, Nephrotic Syndrome Study Network (NEPTUNE), and Matthew G Sampson
Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials., Yuichiro Mori, O Kenrik Duru, Katherine R Tuttle, Shingo Fukuma, Daisuke Taura, Norio Harada, Nobuya Inagaki, and Kosuke Inoue
Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults With Prediabetes: Systematic Review and Meta-analysis of Randomized Controlled Trials., Yuichiro Mori, O Kenrik Duru, Katherine R Tuttle, Shingo Fukuma, Daisuke Taura, Norio Harada, Nobuya Inagaki, and Kosuke Inoue
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD., Amy K Mottl, Radica Alicic, Christos Argyropoulos, Frank C Brosius, Michael Mauer, Mark Molitch, Robert G Nelson, Leigh Perreault, and Susanne B Nicholas
GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease, Joshua J Neumiller, Radica Alicic, and Katherine R. Tuttle
Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors., Joshua J Neumiller, Fredrick J Lienhard, Radica Alicic, and Katherine Tuttle
Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors., Joshua J Neumiller, Fredrick J Lienhard, Radica Z Alicic, and Katherine R Tuttle
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists., Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Alicic, and Katherine Tuttle
ASN In The Loop: “Disparities in the Use of Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-like Peptie-1 Receptor Agonist in Adults with Chronic Kidney Disease”, Susanne B. Nicholas, Radica Alicic, and Jenny Shen
Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Elizabeth S Brooks, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, and Nagy A Mekhail
Elucidating Diversity in Obesity-Related Phenotypes Using Longitudinal and Multi-omic Approaches, Brian D. Piening, Alexa K Dowdell, and Michael P. Snyder
Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action., Janani Rangaswami, Vivek Bhalla, Glenn M Chertow, Robert A Harrington, Alexander Staruschenko, Katherine Tuttle, and Eugene Braunwald
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease., Connie M Rhee, Kamyar Kalantar-Zadeh, and Katherine Tuttle
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease., Connie M Rhee, Kamyar Kalantar-Zadeh, and Katherine Tuttle
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy., Paul M Ridker, Katherine Tuttle, Vlado Perkovic, Peter Libby, and Jean G MacFadyen
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy., Paul M Ridker, Katherine R Tuttle, Vlado Perkovic, Peter Libby, and Jean G MacFadyen
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence., Peter Rossing, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Kamlesh Khunti, Adrian Liew, Erin D Michos, Sankar D Navaneethan, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine Tuttle, Christoph Wanner, Katy G Wilkens, Sophia Zoungas, Jonathan C Craig, David J Tunnicliffe, Marcello A Tonelli, Michael Cheung, Amy Earley, and Ian H de Boer
Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study., Viktor Rotbain Curovic, Neil Roy, Tine W Hansen, M Luiza Caramori, David Z Cherney, Ian H De Boer, Mary Ann Emanuele, Irl B Hirsch, Ildiko Lingvay, Janet B Mcgill, Sarit Polsky, Rodica Pop-Busui, Ronald J Sigal, Katherine R Tuttle, Guillermo E Umpierrez, Amisha Wallia, Sylvia E Rosas, Peter Rossing, and PERL Study Group
Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy., Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishnan Sivaraman, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day., Matthew H. Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romanov, Monika K Krzyzanowska, Diana Garbinsky, Bintu Sherif, Jie Janice Pan, Terri A Binder, Nicholas Sauter, Ran Xie, and Marcia S Brose
How Sweet It Is: Managing Hyperglycemic Emergencies, Rosemary Timmerman
ACID1-004: Euglycemic Ketoacidosis and Other Complications of SGLT2 Inhibitors, Katherine Tuttle
Advancing CKD Care Strategies for a Patient-Centered Team-Based Approach, Katherine Tuttle
Advancing Evidence-based Care in Diabetes & CKD, Katherine Tuttle
A Phase 2 Randomized Controlled Trial of Selonsertib in Moderate and Severe Diabetic Kidney Disease – Oral abstracts, Katherine Tuttle
A Promising Weight-Loss Aid Emerges: Diabetes Drugs, Katherine Tuttle
Change in KDIGO Kidney Risk Category with Semaglutide Treatment – A Post-Hoc Analysis of the Sustain 6 Trial, Katherine Tuttle
Diabetic Kidney Disease: How Can We Improve Outcomes?, Katherine Tuttle
Effect of Dual Receptor Agonists on Cardiovascular System and the Kidney, Katherine Tuttle
Fatty Liver Disease in Diabetes: An Overlooked Complication, Katherine Tuttle
GLP-1 Receptor Agonists in Clinical Management of CKD & Diabetes, Katherine Tuttle
GLP-1 Receptor Agonists in Clinical Management of CKD & Diabetes, Katherine Tuttle
Glycemic Management in Diabetes and CKD, Katherine Tuttle
How to implement these heart failure guidelines in ambulatory patients around the world, Katherine Tuttle
Incretins in DKD. Mechanisms of action and clinical evidence, Katherine Tuttle
Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor., Katherine Tuttle
Targeting MR Overactivation, Katherine Tuttle
The Risks & Benefits of Finerenone, Katherine Tuttle
Molecular mechanisms and therapeutic targets for diabetic kidney disease., Katherine Tuttle, Rajiv Agarwal, Charles E Alpers, George L Bakris, Frank C Brosius, Peter Kolkhof, and Jaime Uribarri
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials., Katherine Tuttle, Adeera Levin, Masaomi Nangaku, Takashi Kadowaki, Rajiv Agarwal, Sibylle J Hauske, Amelie Elsäßer, Ivana Ritter, Dominik Steubl, Christoph Wanner, and David C Wheeler
SGLT2 inhibitors as the bedrock of therapy for heart failure., Katherine Tuttle and Janani Rangaswami
Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020., Katherine R Tuttle, Cami R Jones, Kenn B Daratha, Alain K Koyama, Susanne B Nicholas, Radica Z Alicic, O Kenrik Duru, Joshua J Neumiller, Keith C Norris, Nilka Ríos Burrows, and Meda E Pavkov
Study Design of a Phase 2 Trial of the Aldosterone Synthase Inhibitor BI 690517 Alone and in Combination With Empagliflozin in Patients With Diabetic and Non-Diabetic CKD, Katherine Tuttle and See full list of authors in comments
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease., Katherine Tuttle, Leslie Wong, Wendy St Peter, Glenda Roberts, Janani Rangaswami, Amy Mottl, Alan S Kliger, Raymond C Harris, Patrick O Gee, Kevin Fowler, David Cherney, Frank C Brosius, Christos Argyropoulos, Susan E Quaggin, and Diabetic Kidney Disease Collaborative Task Force
Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer., Evan Walgama, Naifa Busaidy, and Mark Zafereo
Heterogeneity in statin responses explained by variation in the human gut microbiome., Tomasz Wilmanski, Sergey A Kornilov, Christian Diener, Matthew P Conomos, Jennifer C Lovejoy, Paola Sebastiani, Eric S Orwoll, Leroy Hood, Nathan D Price, Noa Rappaport, Andrew T Magis, and Sean M Gibbons
Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis., Jarcy Zee, Qian Liu, Abigail R Smith, Jeffrey B Hodgin, Avi Rosenberg, Brenda W Gillespie, Lawrence B Holzman, Laura Barisoni, Laura H Mariani, Nephrotic Syndrome Study Network (NEPTUNE); NEPTUNE Members, and Katherine Tuttle
Submissions from 2021
Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome., Irina Bancos, Betul Ayse Hatipoglu, Kevin C J Yuen, Lakshmi Chandramohan, Sandeep Chaudhari, and Andreas G Moraitis
Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients., Grant V Bochicchio, Stanley A Nasraway, Laura J Moore, Anthony P Furnary, Eden A Nohra, Kelly M Bochicchio, James C Boyd, David I Bruns, Irl B Hirsch, Jean-Charles Preiser, and James S Krinsley
Phase Ic study of the aldosterone synthase inhibitor BI 690517 in patients with diabetic kidney disease, S Bornstein, Katherine Tuttle, and See full list of authors in comments
A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer., Marcia S Brose, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romanov, Monika K Krzyzanowska, Sophie Leboulleux, Terri A Binder, Corina Dutcus, Ran Xie, and Matthew H Taylor
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project., Catherine R Butler, Paul S Appelbaum, Heather Ascani, Mark Aulisio, Catherine E Campbell, Ian H de Boer, Ashveena L Dighe, Daniel E Hall, Jonathan Himmelfarb, Richard Knight, Karla Mehl, Raghavan Murugan, Sylvia E Rosas, John R Sedor, John F O'Toole, Katherine Tuttle, Sushrut S Waikar, Michael Freeman, and Kidney Precision Medicine Project
Annals On Call - SGLT-2 Revisited: Diabetes Management in Chronic Kidney Disease, Robert M. Centor, Katherine Tuttle, and Jonathan Himmelfarb
Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases., Alice Y Chang, Sasan Mirfakhraee, Elizabeth E King, Kelley J Moloney, Diane M Donegan, and Kevin Cj Yuen
Construct validity, ecological validity and acceptance of self-administered online neuropsychological assessment in adults., Naomi S Chaytor, Celestina Barbosa-Leiker, Laura T Germine, Luciana Mascarenhas Fonseca, Sterling M McPherson, and Katherine Tuttle
The role of RENAL score in predicting complications after robotic partial nephrectomy., Jorge Daza, Kennedy E Okhawere, Olajumoke Ige, Amr Elbakry, John P Sfakianos, Ronney Abaza, Akshay Bhandari, Daniel D Eun, Ashok K Hemal, James R Porter, and Ketan K Badani
Rationale and design of the Kidney Precision Medicine Project., Ian H de Boer, Charles E Alpers, Evren U Azeloglu, Ulysses G J Balis, Jonathan M Barasch, Laura Barisoni, Kristina N Blank, Andrew S Bomback, Keith Brown, Pierre C Dagher, Ashveena L Dighe, Michael T Eadon, Tarek M El-Achkar, Joseph P Gaut, Nir Hacohen, Yongqun He, Jeffrey B Hodgin, Sanjay Jain, John A Kellum, Krzysztof Kiryluk, Richard Knight, Zoltan G Laszik, Chrysta Lienczewski, Laura H Mariani, Robyn L McClelland, Steven Menez, Dennis G Moledina, Sean D Mooney, John F O'Toole, Paul M Palevsky, Chirag R Parikh, Emilio D Poggio, Sylvia E Rosas, Matthew R Rosengart, Minnie M Sarwal, Jennifer A Schaub, John R Sedor, Kumar Sharma, Becky Steck, Robert D Toto, Olga G Troyanskaya, Katherine Tuttle, Miguel A Vazquez, Sushrut S Waikar, Kayleen Williams, Francis Perry Wilson, Kun Zhang, Ravi Iyengar, Matthias Kretzler, Jonathan Himmelfarb, and Kidney Precision Medicine Project
New pharmacological therapies to slow the progression of diabetic kidney disease: e-seminar #2 New guidelines to optimize the clinical care of people with diabetes and CKD, Ian De Boer, Katherine Tuttle, and Christoph Wanner
Identification of kidney disease diagnosis in patients with diabetes by biopsies and electronic health records, E Fast, CR Jones, Kenn Daratha, Radica Alicic, Katherine Tuttle, and See all authors in comments
Identification of kidney disease diagnoses in patients with diabetes by biopsies and electronic health records, Eva Fast, Cami R Jones, Kenn Daratha, Susanne B. Nicholas, Radica Alicic, Cynthia C. Nast, Jonathan E. Zuckerman, Sarthak Patel, Ken Allison, Adam Tebbe, Michelle Penny, Keith C. Norris, and Katherine Tuttle
Identification of Kidney Disease Diagnoses in Patients with Diabetes by Biopsies and Electronic Health Records, Eva Fast, Cami R. Jones, Kenn Daratha, Susanne B. Nicholas, Radica Alicic, Cynthia C. Nast, Jonathan E. Zuckerman, Sarthak Patel, Adam Tebbe, Michelle Penny, Keith C. Norris, and Katherine Tuttle
Large-scale, three-dimensional tissue cytometry of the human kidney: a complete and accessible pipeline., Michael J Ferkowicz, Seth Winfree, Angela R Sabo, Malgorzata M Kamocka, Suraj Khochare, Daria Barwinska, Michael T Eadon, Ying-Hua Cheng, Carrie L Phillips, Timothy A Sutton, Katherine J Kelly, Pierre C Dagher, Tarek M El-Achkar, Kenneth W Dunn, Kidney Precision Medicine Project, and Katherine Tuttle
MRA’s in the future of DKD Management, Roberto Pecoits Filho, Katherine Tuttle, and See full list of authors in comments
Consensus on diagnosis and management of Cushing's disease: a guideline update., Maria Fleseriu, Richard Auchus, Irina Bancos, Anat Ben-Shlomo, Jerome Bertherat, Nienke R Biermasz, Cesar L Boguszewski, Marcello D Bronstein, Michael Buchfelder, John D Carmichael, Felipe F Casanueva, Frederic Castinetti, Philippe Chanson, James Findling, Mônica Gadelha, Eliza B Geer, Andrea Giustina, Ashley Grossman, Mark Gurnell, Ken Ho, Adriana G Ioachimescu, Ursula B Kaiser, Niki Karavitaki, Laurence Katznelson, Daniel F Kelly, André Lacroix, Ann McCormack, Shlomo Melmed, Mark Molitch, Pietro Mortini, John Newell-Price, Lynnette Nieman, Alberto M Pereira, Stephan Petersenn, Rosario Pivonello, Hershel Raff, Martin Reincke, Roberto Salvatori, Carla Scaroni, Ilan Shimon, Constantine A Stratakis, Brooke Swearingen, Antoine Tabarin, Yutaka Takahashi, Marily Theodoropoulou, Stylianos Tsagarakis, Elena Valassi, Elena V Varlamov, Greisa Vila, John Wass, Susan M Webb, Maria C Zatelli, and Beverly M K Biller
Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes., Rodolfo J Galindo, Francisco J Pasquel, Priyathama Vellanki, Radica Alicic, David W Lam, Maya Fayfman, Alexandra L Migdal, Georgia M Davis, Saumeth Cardona, Maria A Urrutia, Citlalli Perez-Guzman, Karla Walkiria Zamudio-Coronado, Limin Peng, Katherine Tuttle, and Guillermo E Umpierrez
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol., Anastasia Gant Kanegusuku, Katherine A Araque, Hung Nguyen, Bin Wei, Saman Hosseini, and Steven J Soldin
"Young children are not the same as adolescents when it comes to treating thyroid cancer"., Melanie Goldfarb, Emily Christison-Lagay, Jeff Rastatter, and Jonathan Wasserman
Population Health Innovations and Payment to Address Social Needs Among Patients and Communities With Diabetes., Kathryn E Gunter, Monica E Peek, Jacob P Tanumihardjo, Evalyn Carbrey, Richard D Crespo, Trista W Johnson, Brenda Rueda-Yamashita, Eric I Schwartz, Catalina Sol, Cody M Wilkinson, J O Wilson, Emily Loehmer, and Marshall H Chin
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial., Jacqueline Halton, Leonardo R Brandão, Matteo Luciani, Lisa Bomgaars, Elizabeth Chalmers, Lesley G Mitchell, Ildar Nurmeev, Anjali Sharathkumar, Pavel Svirin, Kirill Gorbatikov, Igor Tartakovsky, Monika Simetzberger, Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Paul Reilly, Martina Brueckmann, Manuela Albisetti, DIVERSITY Trial Investigators, and Judy Felgenhauer (DIVERSITY Trial Investigator)
Characteristics of patients with chronic kidney disease and diabetes by use of ACE inhibitors of ARBs, CR Jones, Kenn Daratha, Radica Alicic, Katherine Tuttle, and See full list of authors in comments
Nephron overload as a therapeutic target to maximize kidney lifespan., Valerie A Luyckx, Andrew D Rule, Katherine Tuttle, Pierre Delanaye, Helen Liapis, Afschin Gandjour, Paola Romagnani, and Hans-Joachim Anders
Nephron overload as a therapeutic target to maximize kidney lifespan, Valerie A. Luyckx, Andrew D. Rule, Katherine Tuttle, Pierre Delanaye, Helen Liapis, Afschin Gandjour, Paola Romagnani, and Hans-Joachim Anders
Diagnostic pitfalls in Cushing's disease impacting surgical remission rates; test thresholds and lessons learned in 105 patients., Regin Jay Mallari, Jai Deep Thakur, Garni Barkhoudarian, Amy Eisenberg, Amanda Rodriguez, Sarah Rettinger, Pejman Cohan, Lynnette Nieman, and Daniel F Kelly
In Reply - Neutralization of Fecal Aerosol-Laden SARS CoV-2: Public Health Implications., Carmen V McDermott, Emily J Cox, James M Scanlan, and Radica Alicic
GLP-1 Receptor Agonists in Diabetic Kidney Disease., Erin D Michos and Katherine R Tuttle
The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis., Sarah M Moran, Jennifer Scott, Michael R Clarkson, Niall Conlon, Jean Dunne, Matthew D Griffin, Tomas P Griffin, Elizabeth Groarke, John Holian, Conor Judge, Jason Wyse, Kirsty McLoughlin, Paul V O'Hara, Mark A Little, Matthias Kretzler, Nephrotic Syndrome Study Network (NEPTUNE), and Katherine Tuttle
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists., Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Z Alicic, and Katherine R Tuttle
Disparities in CKD risks: data from the CURE-CKD COVID-19 sub-registry, SB Nicholas, Kenn Daratha, CR Jones, Katherine Tuttle, and See full list of authors in comments
Does glucose influence multidien cycles of interictal and/or ictal activities?, Alexa Pappas, Sanjay Kubsad, Maxime O Baud, Kyla E Wright, Devon M Kollmyer, Nicole M Warner, Alan M Haltiner, Ryder P Gwinn, and Michael J Doherty
A Comprehensive Assessment of Associations between Prenatal Phthalate Exposure and the Placental Transcriptomic Landscape., Alison G Paquette, James MacDonald, Samantha Lapehn, Theo Bammler, Laken Kruger, Drew B Day, Nathan D Price, Christine Loftus, Kurunthachalam Kannan, Carmen Marsit, W Alex Mason, Nicole R Bush, Kaja Z LeWinn, Daniel A Enquobahrie, Bhagwat Prasad, Catherine J Karr, and Sheela Sathyanarayana
TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p., Girijesh Kumar Patel, Sayanika Dutta, Mosharaf Mahmud Syed, Sabarish Ramachandran, Monica Sharma, Venkatesh Rajamanickam, Vadivel Ganapathy, David J DeGraff, Kevin Pruitt, Manisha Tripathi, and Srinivas Nandana
Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Elizabeth S Brooks, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Christopher A Paul, Neel D Mehta, Heejung Choi, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Gennady Gekht, Charles E Argoff, Christian E Nasr, Rod S Taylor, Jeyakumar Subbaroyan, Bradford E Gliner, David L Caraway, and Nagy A Mekhail
Integrated Personal Omics Profiling for Obesity, Brian D. Piening
Maintaining operational excellence during the COVID-19 pandemic in the FLOW trial, RE Pratley, Katherine Tuttle, and See full list of authors in comments
#26 Cardiorenal Protection with Newer Antidiabetic Agents, Janani Rangaswami, Vivek Bhalla, Katherine Tuttle, and Muthiah Vaduganathan
Facebook Live: HMR Weight Management: Insights into Successful Weight Loss, Rick Riess and Frances Broyles
Influence of Socioeconomic Status on Incident Medical Conditions in Two-Year Survivors of Adolescent or Young Adult Differentiated Thyroid Cancer., Thomas J Semrad, Qian Li, Melanie Goldfarb, Alison Semrad, Michael Campbell, D Gregory Farwell, and Theresa H M Keegan
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies., Paras P Shah, Tammy M Brady, Kevin E C Meyers, Michelle M O'Shaughnessy, Keisha L Gibson, Tarak Srivastava, Jarcy Zee, Daniel Cattran, Katherine Tuttle, Crystal Gadegbeku, Dorey Glenn, Vimal Derebail, Abigail Smith, Chia-Shi Wang, Brenda W Gillespie, Markus Bitzer, and Christine B Sethna
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies., Paras P Shah, Tammy M Brady, Kevin E C Meyers, Michelle M O'Shaughnessy, Keisha L Gibson, Tarak Srivastava, Jarcy Zee, Daniel Cattran, Katherine Tuttle, Crystal Gadegbeku, Dorey Glenn, Vimal Derebail, Abigail Smith, Chia-Shi Wang, Brenda W Gillespie, Markus Bitzer, and Christine B Sethna
Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium., Jung-Im Shin, Alex R Chang, Morgan E Grams, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Kunihiro Matsushita, Henk J G Bilo, Juan J Carrero, Gabriel Chodick, Kenn B Daratha, Girish N Nadkarni, Robert G Nelson, Christoph Nowak, Nikita Stempniewicz, Keiichi Sumida, Jamie P Traynor, Mark Woodward, Yingying Sang, Ron T Gansevoort, and CKD Prognosis Consortium
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference., Michael G Shlipak, Sri Lekha Tummalapalli, L Ebony Boulware, Morgan E Grams, Joachim H Ix, Vivekanand Jha, Andre-Pascal Kengne, Magdalena Madero, Borislava Mihaylova, Navdeep Tangri, Michael Cheung, Michel Jadoul, Wolfgang C Winkelmayer, Sophia Zoungas, Conference Participants, and Radica Alicic
Esophageal Necrosis as an Unexpected Complication of Diabetic Ketoacidosis, Hayden Smith and Tricia James
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study., Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles, Christina S Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F Gainor, Gilberto Lopes, Chia-Chi Lin, Yann Godbert, Debashis Sarker, Stephen G Miller, Corinne Clifford, Hui Zhang, Christopher D Turner, and Matthew H Taylor
